Search research articles
Contact Us
Filters
Showing results (141-150 of 182) with videos related to
Page
of 19
Sort By:
European Journal of Gastroenterology & Hepatology
|
February 21, 1998
The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying
H A Gielkens, S Y de Boer, W F Lam, et al.
Drug Metabolism and Drug Interactions
|
April 23, 2010
Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro
Stefano Persiani, Anne Matthews, Patrice Larger, et al.
Acta Crystallographica. Section D, Structural Biology
|
December 3, 2025
Structure, substrate recognition and therapeutic targeting of the human ADAMTS-5 spacer domain
Mario Milani, Michela Visintin, Ivet Krastanova, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 4, 2009
Development and validation of a HPLC-ES-MS/MS method for the determination of glucosamine in human synovial fluid
E Pastorini, R Rotini, M Guardigli, et al.
Osteoarthritis and Cartilage
|
December 31, 2002
Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
O Bruyere, A Honore, O Ethgen, et al.
Regulatory Peptides
|
October 21, 1994
Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans
M L Verhulst, H A Gielkens, W P Hopman, et al.
European Journal of Clinical Investigation
|
September 1, 1993
Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man
M C Jebbink, J B Jansen, F G van der Kleij, et al.
British Journal of Cancer
|
June 1, 1992
Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth
S A Watson, D M Crosbee, D L Morris, et al.
European Journal of Clinical Investigation
|
October 1, 1991
Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion
W E Schmidt, W Creutzfeldt, M Höcker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1993
Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism
R J Lieverse, J B Jansen, A van de Zwan, et al.
Page
of 19
Search research articles
Search
Showing results (141-150 of 182) with videos related to
Sort By:
Page
of 19
European Journal of Gastroenterology & Hepatology
|
February 21, 1998
The role of cholecystokinin and the cholinergic system in intravenous amino acid-induced gallbladder emptying
H A Gielkens, S Y de Boer, W F Lam, et al.
Drug Metabolism and Drug Interactions
|
April 23, 2010
Glucosamine binding to proteins in plasma and synovial fluid and blood cell/plasma partitioning in mouse and man in vitro
Stefano Persiani, Anne Matthews, Patrice Larger, et al.
Acta Crystallographica. Section D, Structural Biology
|
December 3, 2025
Structure, substrate recognition and therapeutic targeting of the human ADAMTS-5 spacer domain
Mario Milani, Michela Visintin, Ivet Krastanova, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
August 4, 2009
Development and validation of a HPLC-ES-MS/MS method for the determination of glucosamine in human synovial fluid
E Pastorini, R Rotini, M Guardigli, et al.
Osteoarthritis and Cartilage
|
December 31, 2002
Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulfate
O Bruyere, A Honore, O Ethgen, et al.
Regulatory Peptides
|
October 21, 1994
Loxiglumide inhibits cholecystokinin stimulated somatostatin secretion and simultaneously enhances gastric acid secretion in humans
M L Verhulst, H A Gielkens, W P Hopman, et al.
European Journal of Clinical Investigation
|
September 1, 1993
Effect of duodenal juice on bombesin-stimulated cholecystokinin release during loxiglumide administration in man
M C Jebbink, J B Jansen, F G van der Kleij, et al.
British Journal of Cancer
|
June 1, 1992
Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth
S A Watson, D M Crosbee, D L Morris, et al.
European Journal of Clinical Investigation
|
October 1, 1991
Cholecystokinin receptor antagonist loxiglumide modulates plasma levels of gastro-entero-pancreatic hormones in man. Feedback control of cholecystokinin and gastrin secretion
W E Schmidt, W Creutzfeldt, M Höcker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1993
Bombesin reduces food intake in lean man by a cholecystokinin-independent mechanism
R J Lieverse, J B Jansen, A van de Zwan, et al.
Page
of 19